MAPS Germany Chapter Launch 2026
12 February 2026 • 09:00–16:00 CET • Andaz Munich Schwabinger Tor, Munich
Germany-first working forum
CMD-led, affiliate reality
Take-home outputs
Frameworks + templates
Non-promotional
Scenario-led discussion
Germany-first. CMD-led. Built for execution.
A practical working forum for Germany Medical Affairs leaders focused on three priorities for 2026: GenAI governance, AMNOG/G-BA evidence readiness, and the medical–commercial interface — with take-home tools you can use immediately.
You will leave with:
- AI Use-Case Decision Framework (Germany MA) — decision criteria + minimum documentation
- AMNOG/G-BA Evidence Readiness Checklist — what to build upstream, before access pressure hits
- Minimum viable operating model — decision rights + escalation + documentation for the interface
Agenda
At-a-glance schedule (all times CET). Session facilitators will be confirmed as the programme finalises.
| Time (CET) | SESSION |
|---|---|
| 09:00–10:00 | Arrival, registration & coffee |
| 10:00–10:10 | Welcome & framing: why this forum / how the day works |
| 10:10–10:55 | CMD Priorities Roundtable – 2026 Execution Priorities for Germany |
| 10:55–11:45 | GenAI Governance in German Medical Affairs – Policy, Risk, and Operating Model |
| 11:45–12:05 | Coffee break |
| 12:05–12:50 | Evidence → Access in Germany: AMNOG / G-BA / HTA readiness |
| 12:50–13:50 | Lunch & peer networking |
| 13:50–14:35 | Medical–Commercial interface in Germany (without crossing lines) |
| 14:35–14:55 | Coffee break |
| 14:55–15:40 | Practical Clinic: Build the tools (“what you’ll use on Monday”) |
| 15:40–16:00 | Closing: priorities, commitments, and post-event outputs |
Session outcomes
CMD Priorities Roundtable: Germany MA in 2026
- Output: “Top 3 Germany MA priorities for 2026” + “Top 3 operating moves” validated live by the room.
- Format: Facilitated roundtable with structured prompts; MAPS captures takeaways for post-event distribution.
Headline Session: GenAI in German Medical Affairs: Germany MA in 2026
- Output: AI use-case decision framework for Medical Affairs + minimum viable governance controls and documentation artefacts.
- Format: Short framing + moderated discussion focused on operating model, risk, approvals, and implementation.
Evidence → Access in Germany: AMNOG / G-BA / HTA
- Output: Evidence readiness checklist (what MA should have ready pre-/post-launch for Germany evidence and access expectations).
- Format: Expert-led walkthrough + scenario-based Q&A grounded in Germany affiliate realities.
Medical–Commercial Interface in Germany (Without Crossing Lines)
- Output: Clear collaboration model (roles, boundaries, escalation paths) to reduce friction while staying compliant.
- Format: Practical scenarios + moderated debate; participants leave with “do / don’t / minimum controls” guidance.
Practical Clinic: Build the Tools
- Output: Reusable starter tools (templates/checklists) mapped to the day’s themes: AI governance, evidence readiness, and interface guardrails.
- Format: Small-group clinic with report-back; MAPS compiles outputs into a post-event pack.
Speakers & CMD Leads
Confirmed presenters and CMD leaders who will facilitate the working sessions.
Sarah Adams
Country Medical Director, Alnylam
Tamas Koncz
President, MAPS EMEA
Tobias Suiter
Germany Country Lead, MAPS
Additional German Medical leaders will be revealed as the programme develops.
Contribute to the Germany Agenda
The Germany Chapter Launch is co-designed with CMDs and senior Medical Affairs leaders. Use the links below to propose a speaker or suggest a priority topic for 2026.
We are prioritising CMDs and CMD-equivalent leaders working in or closely with affiliates in Germany.
Venue
Andaz Munich Schwabinger Tor
Leopoldstraße 170, 80804 Munich, Germany
A centrally located, modern venue with strong access from Munich Airport and major rail connections. The Andaz provides dedicated space suitable for a CMD-led working session
Founding Sponsorship
A limited number of Founding Sponsor opportunities are available for organisations committed to supporting CMD-led Medical Affairs in Germany. Sponsorship is non-promotional, editorially independent, and aligned with MAPS global standards and Germany compliance expectations.
Confirmed sponsors will be displayed here as they are finalised.
- Download Sponsorship Prospectus
- Contact: [email protected]
Pricing:
| Euros | USD | |
|---|---|---|
| Group Rate | €249 + €199 EUR per additional colleague (up to 5 registrants) | $346.80 USD → Your Price: $288.81 |
| Maps Member Rate | €249 EUR | $346.80 USD |
| Non-Member Rate | €299 EUR | $346.80 USD |
Related MAPS Resources
Resource: Embracing Omnichannel in Medical Affairs
Resource: Leadership & Management | Change Management
Resource: Value Assessment for Health Technologies
Resource: Scientific & Technical Knowledge | Medical/Commercial Interface
Resource: Compliance Considerations in Medical/Commercial Collaboration
Resource: Advancing Excellence in Medical Affairs
This meeting is not a deep-dive training on these topics, but if you would like additional context, the MAPS resources below align with the themes of the programme.
